Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15

被引:21
作者
Gómez-Nicola, D
Doncel-Pérez, E
Nieto-Sampedro, M
机构
[1] CSIC, Inst Ramon & Cajal Neurobiol, Neural Plast Dept, Madrid 28002, Spain
[2] Hosp Nacl Paraplejicos, Expt Neurol Unit, Toledo, Spain
关键词
CNS; neuropathic pain; cytokines; gangliosides;
D O I
10.1002/jnr.20777
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The interleukin (IL)-15-dependent immune responses of murine microglia were strongly affected by low concentrations of the ganglioside GD3. The ganglioside binding to IL-15 inhibited the proinflammatory effects of the cytokine, reducing IL-15-dependent T-cell proliferation as well as mRNA expression for IL-15R alpha, p65, and NFATc2 in the N13 murine microglial cell line. Treatment of primary murine microglial cultures with GD3 abolished IL-15 production, without affecting cellular viability, but decreased the production of nitric oxide, a direct sensor of inflammation and nuclear factor-kappa B activity. We conclude that low doses of GD3 could inhibit specific proinflammatory mechanisms and modulate the inflammatory environment, leading to a less reactive scene. Microglial cells are one of the main actors in the inflammatory events that follow CNS trauma or an autoimmune disease episode, modulating the internal production of cytokines, growth factors, and other homeostatic molecules that may determine the evolution and outcome of tissue damage. Proinflammatory cytokines have a relevant role in the initial events, and modulation of their activity by gangliosides could cut down their harmful effects and interfere with invasion of the CNS by peripheral immune cells. The antiinflammatory properties of GD3 could be significant in the treatment of pain subsequent to CNS damage. (C) 2006 Wiley-Liss, Inc.
引用
收藏
页码:754 / 762
页数:9
相关论文
共 65 条
  • [1] Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain
    Abad-Rodríguez, J
    Bernabé, M
    Romero-Ramírez, L
    Vallejo-Cremades, M
    Fernández-Mayoralas, A
    Nieto-Sampedro, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) : 2547 - 2556
  • [2] Immune function of microglia
    Aloisi, F
    [J]. GLIA, 2001, 36 (02) : 165 - 179
  • [3] ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
  • [4] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [5] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [6] NF-kappa B: A pivotal role in asthma and a new target for therapy
    Barnes, PJ
    Adcock, IM
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (02) : 46 - 50
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] GANGLIOSIDE CONTENT OF ASTROGLIA AND NEURONS ISOLATED FROM MATURING RAT-BRAIN - CONSIDERATION OF THE SOURCE OF ASTROGLIAL GANGLIOSIDES
    BYRNE, MC
    FAROOQ, M
    SBASCHNIGAGLER, M
    NORTON, WT
    LEDEEN, RW
    [J]. BRAIN RESEARCH, 1988, 461 (01) : 87 - 97
  • [9] NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression
    Caetano, MS
    Vieira-De-Abreu, A
    Teixeira, LK
    Werneck, MBF
    Barcinski, MA
    Viola, JPB
    [J]. FASEB JOURNAL, 2002, 16 (12) : 1940 - +
  • [10] Cammer W, 1996, J NEUROSCI RES, V46, P18, DOI 10.1002/(SICI)1097-4547(19961001)46:1<18::AID-JNR3>3.0.CO